6 Meridian’s Abiomed Inc ABMD Stock Holding History

6 Meridian’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-644	Closed	-$205K	–	425
2021 Q1	$205K	Buy	644 +12	+2%	+$3.84K	0.02%	374
2020 Q4	$205K	Buy	+632	New	+$175K	0.02%	284

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

6 Meridian's ABMD Position: Q2 2021 in Review

6 Meridian sold out of Abiomed Inc (ABMD) in Q2 2021, closing a stake of 644 shares — an estimated $205K sold.

6 Meridian first reported a position in ABMD in Q4 2020 and held it in 2 quarters. The position peaked at $205K in Q1 2021. 474 funds tracked by Wall St. Rank hold ABMD as of Q2 2021.

6 Meridian reported no remaining Abiomed Inc position as of Q2 2021 after selling out during the quarter.
6 Meridian sold 644 Abiomed Inc shares in Q2 2021, an estimated $205K.
6 Meridian first reported a position in Abiomed Inc in Q4 2020 and held it in 2 quarters.
6 Meridian's Abiomed Inc position peaked at $205K in Q1 2021.
474 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2021.

Based on 6 Meridian's 13F filing for Q2 2021, filed 14 Jul 2021.